User profiles for Julia Hippisley-Cox

Julia Hippisley-Cox

Professor of Clinical Epidemiology & General Practice
Verified email at phc.ox.ac.uk
Cited by 27133

[HTML][HTML] The current status of risk-stratified breast screening

…, SM Brady, GS Collins, J Hippisley-Cox - British journal of …, 2022 - nature.com
Apart from high-risk scenarios such as the presence of highly penetrant genetic mutations,
breast screening typically comprises mammography or tomosynthesis strategies defined by …

[HTML][HTML] Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

…, KM Channon, NL Mills, A Sheikh, J Hippisley-Cox - Nature medicine, 2022 - nature.com
Although myocarditis and pericarditis were not observed as adverse events in coronavirus
disease 2019 (COVID-19) vaccine trials, there have been numerous reports of suspected …

Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2

J Hippisley-Cox, C Coupland, Y Vinogradova… - Bmj, 2008 - bmj.com
Objective To develop and validate version two of the QRISK cardiovascular disease risk
algorithm (QRISK2) to provide accurate estimates of cardiovascular risk in patients from different …

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study

J Hippisley-Cox, C Coupland, P Brindle - bmj, 2017 - bmj.com
Julia Hippisley-Cox professor of clinical epidemiology and general practice1, Carol
Coupland professor of medical statistics in primary care1, Peter Brindle evaluation and …

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study

J Hippisley-Cox, C Coupland, Y Vinogradova… - Bmj, 2007 - bmj.com
Objective To derive a new cardiovascular disease risk score (QRISK) for the United Kingdom
and to validate its performance against the established Framingham cardiovascular …

[HTML][HTML] Associations between body-mass index and COVID-19 severity in 6· 9 million people in England: a prospective, community-based, cohort study

…, C Piernas, NM Astbury, J Hippisley-Cox… - The lancet Diabetes & …, 2021 - thelancet.com
Background Obesity is a major risk factor for adverse outcomes after infection with SARS-CoV-2.
We aimed to examine this association, including interactions with demographic and …

[HTML][HTML] Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection

…, R Ravanan, A Sheikh, C Robertson, J Hippisley-Cox - Nature medicine, 2021 - nature.com
Emerging reports of rare neurological complications associated with COVID-19 infection and
vaccinations are leading to regulatory, clinical and public health concerns. We undertook a …

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study

…, F Kee, P Johnson, S Jebb, T Williams, J Hippisley-Cox - bmj, 2020 - bmj.com
Objective To derive and validate a risk prediction algorithm to estimate hospital admission
and mortality outcomes from coronavirus disease 2019 (covid-19) in adults. Design …

Antidepressant use and risk of adverse outcomes in older people: population based cohort study

…, R Morriss, A Arthur, G Barton, J Hippisley-Cox - Bmj, 2011 - bmj.com
… , Antony Arthur associate professor in elder care3, Garry Barton senior lecturer in health
economics4, Julia Hippisley-Cox professor of clinical epidemiology and general practice1 …

Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study

J Hippisley-Cox, CAC Coupland, N Mehta, RH Keogh… - bmj, 2021 - bmj.com
Objectives To derive and validate risk prediction algorithms to estimate the risk of covid-19
related mortality and hospital admission in UK adults after one or two doses of covid-19 …